Misidentified DNA leads authors to retract zebrafish cholesterol paper

cov150h

Authors are retracting a 2012 paper on cholesterol metabolism in zebrafish after realizing it included a case of mistaken identity in a DNA sequence crucial to some aspects of the experiment.  

A postdoc misidentified the plasmid in question after failing to fully sequence it before including it in the experiment. A technician in the lab found the mistake, last author Steven Farber, a researcher at the Carnegie Institution for Science in Maryland, explained:

When the omitted region was correctly sequenced we discovered it had an error.

He told us in a phone interview what that felt like:

We were like, holy crap.

Next came months of back and forth with the journal, discussing whether to correct or retract the paper. Farber tells us the mistake, which affects two figures,

was unfortunate. Most of the paper is in fact correct.

The paper, “Visualization of Lipid Metabolism in the Zebrafish Intestine Reveals a Relationship between NPC1L1-Mediated Cholesterol Uptake and Dietary Fatty Acid,” published in Chemistry & Biology, has been cited 21 times, according to Thomson Scientific’s Web of Knowledge.

Here’s the detailed retraction noteContinue reading Misidentified DNA leads authors to retract zebrafish cholesterol paper

Suspicions of data manipulation lead to correction of testicular cancer paper

Screen Shot 2015-12-10 at 5.20.23 PM

The corresponding author of a paper on testicular cancer is telling readers to discount a figure after she learned it may have been manipulated.

Although that one figure in the 2005 paper in the British Journal of Cancer may be problematic, the authors found data to support the other figures, and its conclusions.

This isn’t the first time first author Kerry Manton has faced questions over her data — in 2012, one of her papers was retracted following an investigation by her institution, the Queensland University of Technology. And in 2014, QUT repaid a $275,000 grant after finding Manton

failed to fulfill (her) responsibilities in relation to the responsible dissemination of research findings and that this, coupled with a failure to correct the errors, constituted research misconduct.

Here’s the corrigendum for “Hypermethylation of the 5′ CpG island of the gene encoding the serine protease Testisin promotes its loss in testicular tumorigenesis:”

Continue reading Suspicions of data manipulation lead to correction of testicular cancer paper

Retractions follow misconduct by biologist, one more on the way

Screen Shot 2016-01-06 at 11.11.12 AM

Two journals have retracted papers by a biologist at the University of Tokyo who admitted to scientific misconduct, including data duplication and misrepresentation. Another journal is planning to retract one of the researcher’s papers later this month.

Hyun Kim studies a protein known as the “ski protein.” However, one analysis of the role of ski protein in development was retracted late last month by the Asian-Australasian Journal of Animal Sciences. The journal decided to investigate after Kim admitted to misconduct in two other papers published in a different journal.

Here’s the note for the paper:

Continue reading Retractions follow misconduct by biologist, one more on the way

Prostate cancer paper retracted after investigation can’t review original image

1.coverAn article about how a COX-2 inhibitor (celecoxib) inhibits growth of prostate cancer in rats is being retracted after the authors were unable to provide an investigation committee at New York University with the backup they were asking for.

When the paper was published in 2003, first author Bhagavathi Narayanan worked at the Institute for Cancer Prevention in New York (also known as the American Health Foundation). But when the institute went broke the next year — thanks partly to lavish salaries and offices, as the New York Post reported —  the authors claim they could no longer obtain back up for an image in the paper, once it was questioned years later by NYU, where Narayanan is now based.

Here’s the retraction note, published in Clinical Cancer Research:

Continue reading Prostate cancer paper retracted after investigation can’t review original image

Four retractions follow Swedish government findings of negligence, dishonesty

242915_1uu_logoA Swedish ethical review board has censured two biologists and their employer, Uppsala University, for events related to “extensive image manipulations” in five papers published between 2010 and 2014. The case has led to criticism from an outside expert — who brought the allegations to Uppsala — over the current system in Sweden for handling such investigations.

Four of the papers have been retracted, and the authors have requested a correction in the fifth.

After an eight-month investigation, in September the government-run Expert Group for Scientific Misconduct at the Central Ethical Review Board in Stockholm, Sweden, concluded that Uppsala professor Kenneth Söderhäll — who has published more than 200 papers — and lecturer Irene Söderhäll acted “negligently” and “dishonestly” by Continue reading Four retractions follow Swedish government findings of negligence, dishonesty

A bullshit excuse? My lab notebook “was blown into a manure pit”

CleanA researcher who studies how to turn dairy cattle manure into natural gas falsified and fabricated data in a journal article and failed to declare a commercial conflict of interest, a Washington State University investigation has found.

The study “Evaluation of Co-Digestion at a Commercial Dairy Anaerobic Digester” was published in 2011 in the journal CLEAN: Soil, Air, Water. First author Craig Frear was a Ph.D. student at WSU Pullman when the study was carried out and an assistant professor at the time of the investigation. The editor-in-chief of CLEAN, Prisca Henheik, told us that the retraction is a done deal even though it has not been posted online: Continue reading A bullshit excuse? My lab notebook “was blown into a manure pit”

Cancer study pulled when published without supervisor’s consent

turkish jThe Turkish Journal of Medical Sciences has retracted a paper after concerns surfaced from a researcher who claims to have supervised the research but was not listed as a co-author.

The first author completed the research — which explored the use of epigenetic alterations as potential early signs of cancer — as part of her master’s degree, under the supervision of Muy-Teck Teh at the Barts & The London School of Medicine & Dentistry. When Teh contacted the journal to say he had not consented to the publication, Ayesha Umair claimed she had paid for the research herself.

Here’s the retraction note for “Quantitative study of epigenetic signature in head and neck squamous cell carcinoma,” which tells us more about the dispute: Continue reading Cancer study pulled when published without supervisor’s consent

Nature retracts paper six years after it was flagged for fraud

cover_natureNature retracted a paper on protein structures today, six years after an investigation at the University of Alabama identified several structures that were “more likely than not falsified and/or fabricated” by one of the authors.

The paper came under scrutiny soon after it was published in 2006. A letter published in Nature that same year pointed out “physically implausible features in the structures it described.” That triggered the investigation at the University of Alabama, the result of which was published in 2009, identifying “nine publications related to the same protein structures that should be retracted from various scientific journals.” Everything was pinned on last author H.M. Krishna Murthy, who the investigation determined was “solely responsible for the fraudulent data.”

A 2009 Nature news article on the investigation declared that the “fraud is the largest ever in protein crystallography.”

We’re not sure what took Nature so long to retract the letter, titled “The structure of complement C3b provides insights into complement activation and regulation.” Here’s the note, which explains that not all the authors agreed to the retraction:

Continue reading Nature retracts paper six years after it was flagged for fraud

Why retraction shouldn’t always be the end of the story

rsc-logoWhen researchers raised concerns about a 2009 Science paper regarding a new way to screen for enzymatic activity, the lead author’s institution launched an investigation. The paper was ultimately retracted in 2010, citing “errors and omissions.”

It would seem from this example that the publishing process worked, and science’s ability to self-correct cleaned up the record. But not so to researchers Ferric Fang and Arturo Casadevall.

Fang, of the University of Washington, Seattle, and Casadevall, of Johns Hopkins — who have made names for themselves by studying retractions — note today in an article for Chemistry World that

Continue reading Why retraction shouldn’t always be the end of the story

Third retraction appears for Leiden researcher fired in 2013

Screen Shot 2015-12-21 at 12.18.41 PM

A researcher who was fired from Leiden University Medical Center in 2013 for fraud has notched a third retraction, following an investigation by her former workplace.

When Leiden fired Annemie Schuerwegh, they announced two retractions of papers that contained manipulated data. This third retraction — the last, according to a spokesperson for the center  — is for “a discrepancy between the data reported in the article and the original collected data,” per the note.

The 2011 paper, “Mast cells are the main interleukin 17-positive cells in anticitrullinated protein antibody-positive and -negative rheumatoid arthritis and osteoarthritis synovium” published in Arthritis Research & Therapy, suggests the source of a protein involved in rheumatoid arthritis. It has been cited 51 times, according to Thomson Scientific’s Web of Knowledge.

Here’s the retraction note:

Continue reading Third retraction appears for Leiden researcher fired in 2013